Price $469.18 |
Market Cap
34.82B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
43.8
|
P/B
27.5
|
P/S
9.94
|
Dividend %
-
|
|
P/CF
155.1
|
P/FCF
53.0
|
Op. Cash Flow
830.1K
|
FCF
8.1
|
|
Op. Margin
30.10%
|
Net Margin
22.90%
|
ROE
85.70%
|
ROI
36.70%
|
|
ROA
28.60%
|
EPS Growth
24.40%
|
Current Ratio
0.9
|
Debt/Equity
114.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Generation Bio Co (GBIO) | $2.32 | - | - | 65.9M | Strong Buy |
| Spruce Biosciences Inc (SPRB) | $0.46 | - | - | 45.6M | Strong Buy |
| Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.40 | - | - | 14.8M | Strong Buy |
| Bimi International Medical Inc (BIMI) | $0.03 | - | - | 6.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
